Assignee
HANDA THERAPEUTICS LLC
US·5 granted patents·0 citations·filing 2022–2024
Top patents by PatentIndex Score
5 records- 0185US12558355B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2023·Granted Feb 24, 2026·0 cites·22 claims
- 0281US12544376B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Feb 10, 2026·0 cites·19 claims
- 0381US12465606B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 0481US12433891B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Oct 7, 2025·0 cites·20 claims
- 0579US12478625B2Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and usesHANDA THERAPEUTICS LLC·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →